Minnesota Clinical Study Center

Fridley, Minnesota 55432

We've found

4 trials

at this facility

BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

Status: Enrolling
Updated: 3/20/2013

from

Fridley, MN

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Fridley, MN

A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Fridley, MN

Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Fridley, MN

Use our guide to learn which trials are right for you!